Filter posts

12th Annual BIO Investor Forum Presenting Companies Announced

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: …

CTTI: Use of Central IRBs in Multi-Center Trials to Streamline Clinical Research

Multi-center clinical trials can provide high-quality, statistically-sound evidence to answer medical questions. Earlier this year, …

E&Y Study: 3 Tax Tweaks that Could Spur Job Growth

A new report from Ernst & Young illustrates the economic impact of three tax proposals …

New PhRMA Report: Nearly 300 Vaccines Currently in Development

Today, the Pharmaceutical Research and Manufacturers of America released a report, Medicines in Development: Vaccines …

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

NCATS R&D Day Aimed At Linking Investors to Preclinical Drug Development Projects

On behalf of the National Center for Advancing Translational Sciences (NCATS), I invite BIO stakeholders …

BIO Welcomes Five New Board Members

BIO elected five new members to its Board of Directors, voted upon at this year’s …

JOBS Act Provides Innovators with Capital Boost

Despite all the talk of gridlock and polarization in Washington these days, successful, bipartisan pieces …

Patent Trolls and Patent Litigation: The GAO Weighs In

Patent troll litigation alarmist were likely disappointed by the GAO report.  While the public discourse …

Driving Innovation in Breast Cancer: Startup Challenge

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for …